These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 4397374)

  • 1. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
    Levy JV
    J Clin Pharmacol New Drugs; 1971; 11(4):249-60. PubMed ID: 4397374
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 3. Nutritional circulation in the heart. 3. Effect of isoproterenol and beta adrenergic blockade on myocardial hemodynamics and rubicium-86 extraction in the isolated supported heart preparation.
    Somani P; Laddu AR; Hardm HF
    J Pharmacol Exp Ther; 1970 Dec; 175(3):577-92. PubMed ID: 4395225
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of adrenergic beta receptor blockaders on the circulation in cats].
    Greeff K; Köhler E
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(1):79-86. PubMed ID: 4397216
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary vascular and cardiac effects of glucagon before and after adrenergic beta-receptor blockade.
    Madan BR; Gupta RS; Jain BK
    Indian J Physiol Pharmacol; 1971 Oct; 15(4):173-7. PubMed ID: 4401547
    [No Abstract]   [Full Text] [Related]  

  • 7. Direct and beta-adrenoreceptor blocking effects of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB-46) on myocardial hemodynamics.
    Laddu AR; Somani P
    Arch Int Pharmacodyn Ther; 1972 Mar; 196(1):5-15. PubMed ID: 4400602
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system].
    Takenaka F; Ishihara T; Maruyama Y; Matsumoto S; Inoue H
    Nihon Yakurigaku Zasshi; 1974 May; 70(3):385-97. PubMed ID: 4155394
    [No Abstract]   [Full Text] [Related]  

  • 10. Blockade of cardiac effects of isoproterenol by 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172).
    Somani P; Laddu AR
    J Pharmacol Exp Ther; 1969 Nov; 170(1):72-8. PubMed ID: 4390814
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the myocardial depressant effect of KL 255: a beta adrenergic receptor antagonist.
    Pendleton RG; Petta JM; Hahn RA
    Arch Int Pharmacodyn Ther; 1970 Sep; 187(1):75-87. PubMed ID: 4394700
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug.
    Giudicelli JF; Schmitt H; Boissier JR
    J Pharmacol Exp Ther; 1969 Jul; 168(1):116-26. PubMed ID: 5792677
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].
    Nakanishi M; Imamura H; Nakamura T; Kimura T
    Yakugaku Zasshi; 1972 Apr; 92(4):375-83. PubMed ID: 4403075
    [No Abstract]   [Full Text] [Related]  

  • 14. Trasicor: review of the pharmacology and clinical results.
    Fuccella LM
    S Afr Med J; 1969 Dec; ():Suppl:7-14. PubMed ID: 4190429
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197).
    Privitera PJ; Blickenstaff T; Gaffney TE; Mohammed S
    J Pharmacol Exp Ther; 1971 Mar; 176(3):655-61. PubMed ID: 4398744
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of oxprenolol on coronary circulation and cardiac metabolism.
    Drimal J; Aviado DM
    J Pharmacol Exp Ther; 1971 Feb; 176(2):312-9. PubMed ID: 4398185
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

  • 18. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist.
    Hastings SG; Smith RD; Corey RM; Essenburg AD; Pettway CE; Tessman DK
    Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):81-99. PubMed ID: 17372
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical pharmacology of beta-sympathicolysis. Comparative trial of LB 46 and propranolol].
    Lang E; Haas W; Heck J
    Med Klin; 1970 Dec; 65(50):2206-11. PubMed ID: 4399179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.